Search

Your search keyword '"Matsumoto, Hirotaka"' showing total 308 results

Search Constraints

Start Over You searched for: Author "Matsumoto, Hirotaka" Remove constraint Author: "Matsumoto, Hirotaka" Search Limiters Full Text Remove constraint Search Limiters: Full Text
308 results on '"Matsumoto, Hirotaka"'

Search Results

8. Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer

9. Comparative Study of Cardiovascular Effects of Selected Pulmonary Vasodilators in Canine Models of Mitral Valve Disease.

12. IL‐27 produced during acute malaria infection regulates Plasmodium‐specific memory CD4+ T cells

14. Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study

16. NeTaGFT: A similarity network‐based method for trait analysis.

19. A novel ex vivo lung cancer model based on bioengineered rat lungs

24. IL‐27 produced during acute malaria infection regulates Plasmodium‐specific memory CD4+ T cells.

25. Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility

35. Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.

36. Early embryonic mutations reveal dynamics of somatic and germ cell lineages in mice

39. A case of juvenile form of dilated cardiomyopathy in a 6-month-old Shiba Inu dog

40. A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC

46. Novel metric for hyperbolic phylogenetic tree embeddings

47. Additional file 2 of Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study

48. Additional file 1 of Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study

49. Additional file 3 of Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study

Catalog

Books, media, physical & digital resources